手臂优势侧与肩关节置换术后临床有意义差异的相关性
这项回顾性比较研究分析了2152例初次解剖或反式全肩关节置换术肩膀,其中65%为优势侧。结果显示,优势侧与非优势侧在12个月时达到MCID或PASS的比例无临床重要差异,但约四分之一肩膀未达到QuickDASH的MCID。
要点
- 优势侧与非优势侧肩关节置换术后12个月达到MCID或PASS的比例无临床重要差异。
- 约25%的肩膀未达到QuickDASH的MCID,超过10%未达到疼痛MCID,约15%未达到至少一个工具的PASS。
- 手臂优势不应被视为术后恢复预期的主要决定因素。
核心结论
- 手臂优势与肩关节置换术后12个月达到MCID或PASS的可能性无临床重要关联。
- 无论优势侧与否,多达四分之一的患者未达到MCID或PASS阈值。
研究设计与样本
- 回顾性比较研究,分析单一专科骨科机构 longitudinally 维护的肩关节置换登记数据。
- 纳入2006年至2024年因肩袖撕裂关节病或原发性骨关节炎行初次解剖或反式全肩关节置换术且有12个月至少一项PROM随访的患者。
- 共分析2152个肩膀,优势侧组占65%(1404个),平均年龄73岁,两组均以女性为主。
主要发现
- 分布法绝对MCID估计值:SPADI为16,QuickDASH为13,疼痛NRS为1.5(降低),Constant-Murley评分为12。
- 分布法绝对PASS估计值:SPADI为19,QuickDASH为5,疼痛NRS为1.8(降低),Constant-Murley评分为20。
- 12个月时,优势侧与非优势侧肩膀的MCID和PASS应答者比例无临床重要差异,所有绝对风险差异及95%CI均在预设的±10%最小重要差异范围内。
- 调整后的混合效应逻辑回归模型中,优势侧与达到MCID或PASS的 odds 无 meaningful 差异(OR接近1.0,所有CI跨越1)。
关键数值与推荐
- SPADI的MCID为16,PASS为19;QuickDASH的MCID为13,PASS为5;疼痛NRS的MCID为1.5(降低),PASS为1.8(降低);Constant-Murley评分的MCID为12,PASS为20(均为分布法绝对估计值)。
- 敏感性分析使用的基于锚定法的MCID:SPADI为20,QuickDASH为12,疼痛NRS为2.2,Constant-Murley评分为9。
临床怎么用
- 在典型临床实践中,手臂优势不应被视为肩关节置换术后恢复预期的主要决定因素。
- 应关注仍有约四分之一患者未达到MCID或PASS阈值,无论优势侧与否。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Limited available evidence seems to suggest that the increased use of the dominant (versus nondominant) limb may allow for earlier return to function and better ROM in the dominant limb at 12-month follow-up after anatomic or reverse total shoulder arthroplasty (TSA). Nevertheless, whether the earlier achievement of physical therapy milestones is associated with a clinically meaningful difference in patient-reported outcome measures (PROMs) is yet to be determined. QUESTIONS/PURPOSES: (1) What are the 12-month minimum clinically important difference (MCID) and patient acceptable symptom state (PASS) thresholds for the Shoulder Pain and Disability Index (SPADI), QuickDASH, numeric rating scale (NRS) for pain, and Constant-Murley score? (2) Is there a difference between the dominant- and nondominant-side TSAs in terms of the proportions of patients achieving an MCID or PASS at 12-month follow-up? METHODS: This retrospective, comparative study analyzed data from a longitudinally maintained shoulder arthroplasty registry at a specialized orthopaedic institution. Patients were eligible for inclusion if they underwent primary anatomic or reverse TSA from 2006 to 2024 for cuff tear arthropathy or primary osteoarthritis and had 12-month follow-up for at least one PROM. We collected relevant baseline patient-related and procedure-related characteristics. The main association of interest was operated limb relative to limb dominance, and shoulders were stratified into the dominant-side or nondominant-side group. A total of 2152 shoulders, 65% (1404) of which were in the dominant-side group, were analyzed. The mean age was 73 years, and the majority of patients were women in both groups. In the dominant group, more patients were treated for cuff tear arthropathy, and a larger proportion received a reverse TSA. Loss to follow-up at 12 months did not differ between groups, reaching 13% for the dominant group and 16% for the nondominant group. The PROMs collected were the SPADI, QuickDASH, NRS for pain, and Constant-Murley score. These were administered at baseline and at 12 months postoperatively. The MCID and PASS thresholds for the PROMs of interest were estimated using a distribution-based approach. A sensitivity analysis was performed using the best available evidence for anchor-based MCIDs (20 for the SPADI, 12 for the QuickDASH, 2.2 for the NRS for pain, and 9 for the Constant-Murley score). Adjusted comparisons of distribution-based MCID estimates and PASS proportions between dominant- and nondominant-side procedures were conducted using generalized linear mixed-effects logistic regression models. Models were adjusted for admission type, surgical indication, procedure type, cuff tear severity, BMI, baseline ROM (forward flexion, abduction, external rotation), and baseline QuickDASH, with a random intercept for patient ID to account for within-patient clustering. Results are reported as ORs with 95% confidence intervals (CIs). RESULTS: Distribution-based absolute MCID estimates were 16 for SPADI, 13 for QuickDASH, 1.5 (reduction) for NRS for pain, and 12 for Constant-Murley score. Distribution-based absolute PASS estimates were 19 for SPADI, 5 for QuickDASH, 1.8 (reduction) for NRS for pain, and 20 for Constant-Murley score. At 12 months, MCID and PASS responder proportions did not differ in clinically important ways between dominant and nondominant shoulders, but approximately 25% (509 of 2120) of shoulders did not achieve the MCID for the QuickDASH, more than 10% (247 of 2123) did not achieve it for pain, and approximately 15% did not achieve a PASS for one or more outcomes tool. All absolute risk differences and 95% CIs fell within the prespecified ± 10% smallest important difference margin, indicating no clinically important dominance effect. In adjusted mixed-effects logistic regression models, dominance was not associated with meaningful differences in the odds of achieving MCID or PASS for SPADI, QuickDASH, NRS for pain, or Constant-Murley score (ORs near 1.0, with all CIs crossing unity). Across all sensitivity analyses, arm dominance demonstrated no association with 12-month MCID or PASS after TSA. CONCLUSION: Arm dominance was not meaningfully associated with an increased or decreased likelihood of achieving MCID or PASS across multiple PROMs. However, as many as 1 in 4 patients did not reach MCID or PASS thresholds after TSA, irrespective of arm dominance. These findings indicate that, in typical clinical practice, dominance should not be considered a major determinant of postoperative recovery expectations. LEVEL OF EVIDENCE: Level III, therapeutic study.
引用
- Lazaridou A, Giannakis P, Schneller T, et al. Is Arm Dominance Associated With Clinically Meaningful Differences in Outcomes After Shoulder Arthroplasty? Clin Orthop Relat Res. 2026. PMID: 41758764. doi:10.1097/CORR.0000000000003869
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。